20 related articles for article (PubMed ID: 2941494)
1. Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy.
D'Atri S; Fuggetta MP; Giganti G; Tentori L; Roselli M; Nunziata C; Pastore S; Bonmassar E; De Vecchis L
Cancer Immunol Immunother; 1988; 27(2):163-70. PubMed ID: 3416325
[TBL] [Abstract][Full Text] [Related]
2. Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.
Simons PJ; Oostendorp RA; Tas MP; Drexhage HA
Cancer Immunol Immunother; 1994 Mar; 38(3):178-84. PubMed ID: 8124686
[TBL] [Abstract][Full Text] [Related]
3. Creation of phosphorylation sites in proteins: construction of a phosphorylatable human interferon alpha.
Li BL; Langer JA; Schwartz B; Pestka S
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):558-62. PubMed ID: 2911594
[TBL] [Abstract][Full Text] [Related]
4. Combined interferon and vinblastine treatment of advanced melanoma: evaluation of the treatment results and the effects of the treatment on immunological functions.
Kellokumpu-Lehtinen P; Nordman E; Toivanen A
Cancer Immunol Immunother; 1989; 28(3):213-7. PubMed ID: 2784356
[TBL] [Abstract][Full Text] [Related]
5. Biology of natural killer cells.
Trinchieri G
Adv Immunol; 1989; 47():187-376. PubMed ID: 2683611
[TBL] [Abstract][Full Text] [Related]
6. Interferon receptors.
Branca AA
In Vitro Cell Dev Biol; 1988 Mar; 24(3):155-65. PubMed ID: 2450859
[No Abstract] [Full Text] [Related]
7. A species of human alpha interferon that lacks the ability to boost human natural killer activity.
Ortaldo JR; Herberman RB; Harvey C; Osheroff P; Pan YC; Kelder B; Pestka S
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4926-9. PubMed ID: 6589637
[TBL] [Abstract][Full Text] [Related]
8. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
9. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
[TBL] [Abstract][Full Text] [Related]
10. Variation in the binding of 125I-labeled interferon-beta ser to cellular receptors during growth of human renal and bladder carcinoma cells in vitro.
Ruzicka FJ; Schmid SM; Groveman DS; Cummings KB; Borden EC
Cancer Res; 1987 Sep; 47(17):4582-9. PubMed ID: 2957045
[TBL] [Abstract][Full Text] [Related]
11. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
Platsoucas CD
Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
[TBL] [Abstract][Full Text] [Related]
12. Binding of human alpha-interferons to natural killer cells.
Langer JA; Ortaldo JR; Pestka S
J Interferon Res; 1986 Apr; 6(2):97-105. PubMed ID: 2941494
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
